Sema Yarman

1.6k total citations
61 papers, 869 citations indexed

About

Sema Yarman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Sema Yarman has authored 61 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Sema Yarman's work include Pituitary Gland Disorders and Treatments (39 papers), Growth Hormone and Insulin-like Growth Factors (22 papers) and Adrenal and Paraganglionic Tumors (22 papers). Sema Yarman is often cited by papers focused on Pituitary Gland Disorders and Treatments (39 papers), Growth Hormone and Insulin-like Growth Factors (22 papers) and Adrenal and Paraganglionic Tumors (22 papers). Sema Yarman collaborates with scholars based in Türkiye, United States and Russia. Sema Yarman's co-authors include Refik Tanakol, Faruk Alagöl, Halil Azizlerli, Harika Boztepe, Sema Çiftçi Doğanşen, Seher Tanrıkulu, Bilge Bılgıç, Fatma Savran Oğuz, Meral Mert and Evin Ademoğlu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Clinica Chimica Acta.

In The Last Decade

Sema Yarman

59 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sema Yarman Türkiye 16 484 248 241 97 97 61 869
Faruk Alagöl Türkiye 17 250 0.5× 192 0.8× 253 1.0× 62 0.6× 117 1.2× 46 723
Vyankatesh Shivane India 14 265 0.5× 143 0.6× 154 0.6× 77 0.8× 107 1.1× 29 580
Cătălina Poiană Romania 14 337 0.7× 184 0.7× 136 0.6× 82 0.8× 57 0.6× 100 697
P. S. N. Menon India 20 587 1.2× 208 0.8× 139 0.6× 125 1.3× 94 1.0× 47 1.1k
Liudmila Rozhinskaya Russia 18 453 0.9× 227 0.9× 303 1.3× 174 1.8× 220 2.3× 184 1.1k
A.D. Rao United States 15 343 0.7× 235 0.9× 108 0.4× 168 1.7× 94 1.0× 30 848
Zhanna Belaya Russia 18 518 1.1× 227 0.9× 255 1.1× 226 2.3× 253 2.6× 173 1.3k
Ilda S. Kunii Brazil 16 187 0.4× 166 0.7× 201 0.8× 128 1.3× 83 0.9× 55 671
Nilgün Güvener Demirağ Türkiye 19 337 0.7× 137 0.6× 107 0.4× 199 2.1× 82 0.8× 42 763
J.C. Souberbielle France 19 328 0.7× 120 0.5× 215 0.9× 185 1.9× 150 1.5× 44 1.3k

Countries citing papers authored by Sema Yarman

Since Specialization
Citations

This map shows the geographic impact of Sema Yarman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sema Yarman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sema Yarman more than expected).

Fields of papers citing papers by Sema Yarman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sema Yarman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sema Yarman. The network helps show where Sema Yarman may publish in the future.

Co-authorship network of co-authors of Sema Yarman

This figure shows the co-authorship network connecting the top 25 collaborators of Sema Yarman. A scholar is included among the top collaborators of Sema Yarman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sema Yarman. Sema Yarman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ertörer, Melek Eda, Seher Tanrıkulu, Pınar Kadıoğlu, et al.. (2025). Aryl hydrocarbon receptor interacting protein and syndromic gene variants detected in Turkish isolated pituitary adenoma families by whole exome sequencing. Scientific Reports. 15(1). 24279–24279.
2.
Doğanşen, Sema Çiftçi, Zeliha Hekimsoy, Şenay Topsakal, et al.. (2024). Comparison of clinical, hormonal, pathological and treatment outcomes of ectopic Cushing’s syndrome by sex: results of a multicenter study. Endocrine. 86(3). 1148–1155. 1 indexed citations
3.
Bingöl, Züleyha, et al.. (2023). Evaluation of pulmonary side effects in prolactinoma patients treated with cabergoline. Endokrynologia Polska. 1 indexed citations
4.
5.
Doğanşen, Sema Çiftçi, Nilüfer Özdemir Kutbay, Seher Tanrıkulu, et al.. (2019). Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 104(7). 2527–2534. 46 indexed citations
6.
Doğanşen, Sema Çiftçi, et al.. (2018). Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center. Endocrine. 60(1). 167–174. 13 indexed citations
7.
Doğanşen, Sema Çiftçi, et al.. (2018). Evaluation of the natural course of thyroid nodules in patients with acromegaly. Pituitary. 22(1). 29–36. 12 indexed citations
8.
Doğanşen, Sema Çiftçi, et al.. (2018). Dynamic changes of central thyroid functions in the management of Cushing's syndrome. Archives of Endocrinology and Metabolism. 62(2). 164–171. 10 indexed citations
9.
Doğanşen, Sema Çiftçi, et al.. (2017). Assessment of macroprolactinemia inpatients with prolactinoma. Turkish Journal of Biochemistry. 43(1). 71–75. 1 indexed citations
10.
Doğanşen, Sema Çiftçi, et al.. (2016). The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas. Growth Hormone & IGF Research. 29. 45–49. 3 indexed citations
11.
Yarman, Sema, et al.. (2015). Do the Aryl Hydrocarbon Receptor Interacting Protein Variants (Q228K and Q307R) Play a Role in Patients with Familial and Sporadic Hormone-Secreting Pituitary Adenomas?. Genetic Testing and Molecular Biomarkers. 19(7). 394–398. 11 indexed citations
12.
Tanrıverdi, Fatih, Hatice Sebila Dökmetaş, Nur Kebapçı, et al.. (2013). Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database. Endocrine. 47(1). 198–205. 54 indexed citations
13.
Tamer, Gonca, Ayşegül Telci, Meral Mert, et al.. (2011). Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed. Endocrine. 41(1). 138–143. 18 indexed citations
14.
Yarman, Sema, et al.. (2011). Interleukin-6-producing pheochromocytoma presenting with fever of unknown origin. Clinics. 66(10). 1843–1845. 22 indexed citations
15.
Bayraktaroğlu, Taner, Harika Boztepe, Sema Yarman, Refik Tanakol, & Faruk Alagöl. (2007). Geç Ortaya Çıkan Tip 1 Otoimmün Poliglandüler Yetersizlik Sendromlu Bir Olgu. Turkiye Klinikleri Tip Bilimleri Dergisi. 27(5). 778–782. 1 indexed citations
16.
Yarman, Sema, et al.. (2007). Interleukin-6-producing pheochromocytoma presenting with fever of unknown origin. 14. 1 indexed citations
17.
Yarman, Sema, Fatma Savran Oğuz, & Mahmut Çarin. (2007). HLA‐DRB1*03 is a susceptibility gene in patients with Graves’ disease with and without ophthalmopathy. International Journal of Immunogenetics. 34(1). 23–25. 8 indexed citations
18.
Türkmen, Cüneyt, et al.. (2007). The value of Tc-99m tetrofosmin in the imaging of pituitary adenomas. Journal of Endocrinological Investigation. 30(2). 86–90. 2 indexed citations
19.
Yarman, Sema, et al.. (2004). Co-Secretion of Aldosterone and Cortisol by an Adrenocortical Carcinoma. Hormone Research in Paediatrics. 62(2). 67–70. 11 indexed citations
20.
Adaş, Mine, Refik Tanakol, Sema Yarman, et al.. (2002). ACUTE RENAL FAILURE ASSOCIATED WITH NONFULMINANT HEPATITIS A VIRUS INFECTION. Renal Failure. 24(1). 97–102. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faruk Alagöl Breakdown of academic impact, for papers by Vyankatesh Shivane Breakdown of academic impact, for papers by Cătălina Poiană Breakdown of academic impact, for papers by P. S. N. Menon Breakdown of academic impact, for papers by Liudmila Rozhinskaya Breakdown of academic impact, for papers by A.D. Rao Breakdown of academic impact, for papers by Zhanna Belaya Breakdown of academic impact, for papers by Ilda S. Kunii Breakdown of academic impact, for papers by Nilgün Güvener Demirağ Breakdown of academic impact, for papers by J.C. Souberbielle
Rankless by CCL
2026